Term Name: dasatinib monohydrate
Synonyms: BMS 354825-03, BMS 35482503, dasatinib, dasatinib hydrate, dasatinib.H2O, N-(2-chloro-6-methylphenyl)-2-((6-(4-(2- hydroxyethyl)piperazin-1-yl)-2-methylpyrimidin-4-yl)amino)thiazole-5-carboxamide hydrate, N-(2-chloro-6-methylphenyl)-2-({6-[4-(2-hydroxyethyl)piperazin-1-yl]-2-methylpyrimidin-4-yl}amino)-1,3-thiazole-5-carboxamide--water (1/1), Sprycel
Definition: A hydrate that is the monohydrate of dasatinib. It is used for the treatment of chronic, accelerated, or myeloid or lymphoid blast phase chronic myeloid leukemia. Note that the name 'dasatinib' is used to refer to the monohydrate (USAN) as well as to anhydrous dasatinib (INN).
Ontology: ChEBI [CHEBI:70839]  ( EBI )

Relationships
is a type of: hydrate
has_part: dasatinib (anhydrous)
has_role: antineoplastic agent tyrosine kinase inhibitor